Pulmonary Artery-to-Vein Volume Difference: A New Imaging Biomarker for Risk Stratification in Acute Pulmonary Embolism
Academic Radiology · 2026-11 · 33 (11) · 5639-5650
DOI: 10.1016/j.acra.2026.08.007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Academic Radiology, 2026-11. Verfasst von Xinyu Song und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Diagnostic and Interventional Radiology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine…. Hauptthemen laut MEDLINE: Pulmonary Embolism, Pulmonary Artery, Computed Tomography Angiography, Pulmonary Veins. Die Arbeit nennt 32 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
RATIONALE AND OBJECTIVES: To propose a new imaging biomarker, the pulmonary artery-to-vein volume difference (PAVVD), and evaluate its efficacy in risk stratification of acute pulmonary embolism (APE) compared with traditional computed tomography pulmonary angiography (CTPA) parameters, as well as the impact of chronic pulmonary disease (CPD). MATERIALS AND METHODS: This retrospective study included 134 patients with APE (high/intermediate-high risk, n = 46; intermediate-low/low risk, n = 88) from April 2023 to March 2024. A commercial artificial intelligence software was used to automatically quantify PAVVD and traditional CTPA parameters. The performances of different CTPA parameters for APE risk stratification were compared using the area under the curve (AUC), diagnostic metrics (e.g., sensitivity, specificity, negative predictive value [NPV], negative likelihood ratio [NLR]), and decision curve analysis (DCA). Multivariate linear regression was conducted to identify factors influencing PAVVD. RESULTS: PAVVD exhibited the highest AUC (0.89, 95% CI: 0.83-0.95) for identifying high/intermediate-high risk APE, with the lowest missed diagnosis risk (NPV = 0.94, NLR = 0.13). DCA demonstrated that PAVVD yielded the highest net benefit within the low-to-moderate threshold probability range. A crossover effect was observed between PAVVD and clot volume: PAVVD performed better when the Qanadli score was
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Diagnostic and Interventional Radiology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Department of Radiology, Shanghai Guanghua Hospital of Integrative Medicine, Shanghai, China.
- Institute of Diagnostic and Interventional Radiology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China. Electronic address: liyuehua0529@163.com.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Song, X., Ye, L., Yan, B., Zhang, R., Wang, S., Chen, Y., Zhou, J., & Li, Y. (2026). Pulmonary Artery-to-Vein Volume Difference: A New Imaging Biomarker for Risk Stratification in Acute Pulmonary Embolism. Academic Radiology, 33(11), 5639-5650. https://doi.org/10.1016/j.acra.2026.08.007
Vancouver
Song X, Ye L, Yan B, Zhang R, Wang S, Chen Y, et al. Pulmonary Artery-to-Vein Volume Difference: A New Imaging Biomarker for Risk Stratification in Acute Pulmonary Embolism. Academic Radiology. 2026;33(11):5639-5650. doi:10.1016/j.acra.2026.08.007
BibTeX
@article{Song2026,
author = {Song, Xinyu and Ye, Lifang and Yan, Bicong and Zhang, Ruipeng and Wang, Shuhao and Chen, Yuanyuan and Zhou, Jia and Li, Yuehua},
title = {Pulmonary Artery-to-Vein Volume Difference: A New Imaging Biomarker for Risk Stratification in Acute Pulmonary Embolism},
journal = {Academic Radiology},
year = {2026},
volume = {33},
number = {11},
pages = {5639--5650},
doi = {10.1016/j.acra.2026.08.007}
}
EUVIMED